Rocío Arroyo, researcher, and CEO of Amadix, leads the team that has created an innovative blood-based test that can detect if a healthy person will develop a malignant colon tumour in the future.
As an entrepreneur, Rocío turned her scientific knowledge into a viable business model securing private investors in Castile and Leon to found Amadix.
Amadix is today a small start-up exceptionally well placed to compete in preventive cancer diagnostics, a market coveted by big pharmaceutical companies.
